| Literature DB >> 20064787 |
Bart Ostro1, Michael Lipsett, Peggy Reynolds, Debbie Goldberg, Andrew Hertz, Cynthia Garcia, Katherine D Henderson, Leslie Bernstein.
Abstract
BACKGROUND: Several studies have reported associations between long-term exposure to ambient fine particulate matter (PM) and cardiovascular mortality. However, the health impacts of long-term exposure to specific constituents of PM(2.5) (PM with aerodynamic diameter < or = 2.5 microm) have not been explored.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20064787 PMCID: PMC2854764 DOI: 10.1289/ehp.0901181
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Descriptive statistics of individual-level pollutant exposures (μg/m3) among participants in the CTS cohort, 1 June 2002 through 31 July 2007 (24-hr averages).
| Participants within 8-km buffer ( | Participants within 30-km buffer ( | |||||
|---|---|---|---|---|---|---|
| Pollutant | Mean | IQR | Range | Mean | IQR | Range |
| PM2.5 | 17.0 | 6.1 | 7.6–34.7 | 17.5 | 6.1 | 6.8–38.7 |
| EC | 1.0 | 0.16 | 0.28–1.8 | 1.1 | 0.65 | 0.20–2.4 |
| OC | 6.1 | 1.0 | 3.1–12.1 | 5.9 | 0.83 | 2.1–10.1 |
| SO4 | 2.0 | 1.3 | 0.6–7.4 | 2.5 | 2.2 | 0.62–7.4 |
| NO3 | 4.5 | 3.6 | 0.7–14.9 | 4.9 | 3.2 | 0.7–16.2 |
| Fe | 0.12 | 0.06 | 0.05–0.34 | 0.14 | 0.13 | 0.04–0.36 |
| K | 0.11 | 0.05 | 0.04–0.35 | 0.11 | 0.07 | 0.02–0.35 |
| Si | 0.14 | 0.05 | 0.04–0.40 | 0.13 | 0.03 | 0.03–0.49 |
| Zn | 0.01 | 0.01 | 0.00–0.03 | 0.01 | 0.01 | 0.00–0.04 |
Baseline characteristics of the CTS participants whose residences were within 8-km and 30-km buffers around PM2.5 species monitors, August 2002–July 2007.
| Individual characteristics | Species 8-km buffer ( | Species 30-km buffer ( |
|---|---|---|
| Age at intake [years (mean ± SD)] | 54.3 ± 13.4 | 53.4 ± 13.0 |
| Race (% white) | 85.9 | 83.4 |
| BMI [mean (kg/m2)] | 25.2 | 25.1 |
| Average dietary fat intake (g/day) | 56.2 | 55.8 |
| Smoking status (%) | ||
| Never smoker | 68.5 | 68.3 |
| Former smoker | 26.1 | 26.9 |
| Current smoker | 5.4 | 4.9 |
| Married (%) | 42.7 | 45.1 |
| Menopausal status (%) | ||
| Premenopausal | 36.2 | 38.3 |
| Peri/postmenopausal and no hormone therapy use | 13.6 | 13.0 |
| Peri/postmenopausal and current/past hormone therapy use | 38.6 | 37.3 |
| Unknown menopausal status/hormone therapy use | 11.6 | 11.4 |
| Family history of heart disease (%) | 33.8 | 34.8 |
| Mean daily dietary calories (kcal) | 1,584 | 1,579 |
| Average no. of pack-years among former and current smokers | 15.6 | 14.6 |
| Adult second-hand smoke exposure (%) | 51.1 | 49.1 |
| Nondrinker (%) | 34.7 | 34.2 |
| Participant locations (proportion within each county) | ||
| Alameda County | 0.3 | 1.7 |
| Fresno County | 16.0 | 5.8 |
| Kern County | 12.0 | 3.3 |
| Los Angeles County | 13.3 | 36.4 |
| Riverside County | 6.6 | 4.4 |
| Sacramento County | 18.3 | 8.4 |
| San Bernardino County | 0.6 | 7.0 |
| San Diego County | 14.1 | 13.6 |
| Santa Clara County | 12.7 | 10.4 |
| Ventura County | 3.0 | 3.0 |
| Other | 3.1 | 6.0 |
Correlations among PM2.5 mass and constituents based on individual-level exposure assessment for the participants within 8-km (top line in each row) and 30-km (bottom line in each row) buffers.
| PM2.5 | EC | OC | SO4 | NO3 | Fe | K | Si | Zn | |
|---|---|---|---|---|---|---|---|---|---|
| PM2.5 | 1.00 | 0.84 | 0.60 | 0.59 | 0.89 | 0.71 | 0.67 | 0.78 | 0.84 |
| 0.82 | 0.64 | 0.72 | 0.90 | 0.76 | 0.66 | 0.80 | 0.91 | ||
| EC | 1.00 | 0.51 | 0.53 | 0.82 | 0.91 | 0.64 | 0.58 | 0.92 | |
| 0.67 | 0.73 | 0.74 | 0.96 | 0.80 | 0.58 | 0.90 | |||
| OC | 1.00 | −0.10 | 0.44 | 0.31 | 0.84 | 0.73 | 0.55 | ||
| 0.29 | 0.48 | 0.55 | 0.87 | 0.71 | 0.61 | ||||
| SO4 | 1.00 | 0.73 | 0.60 | 0.10 | 0.27 | 0.54 | |||
| 0.79 | 0.79 | 0.47 | 0.45 | 0.67 | |||||
| NO3 | 1.00 | 0.79 | 0.50 | 0.74 | 0.83 | ||||
| 0.76 | 0.48 | 0.79 | 0.85 | ||||||
| Fe | 1.00 | 0.50 | 0.51 | 0.85 | |||||
| 0.70 | 0.53 | 0.87 | |||||||
| K | 1.00 | 0.71 | 0.60 | ||||||
| 0.61 | 0.65 | ||||||||
| Si | 1.00 | 0.60 | |||||||
| 0.70 | |||||||||
| Zn | 1.00 | ||||||||
Association between mortality outcomes and PM2.5 and its constituents using 8-km buffer [HRs (95% CIs) for the IQR of each pollutant].
| Pollutant | IQR (μg/m3) | All cause ( | Cardiopulmonary ( | IHD ( | Pulmonary ( |
|---|---|---|---|---|---|
| PM2.5 | 6.1 | 1.49 (1.28–1.74) | 1.58 (1.29–1.93) | 2.10 (1.49–2.97) | 1.39 (0.91–2.11) |
| EC | 0.16 | 1.10 (1.03–1.19) | 1.11 (1.00–1.22) | 1.26 (1.07–1.48) | 0.94 (0.75–1.16) |
| OC | 1.0 | 1.70 (1.53–1.87) | 1.64 (1.44–1.87) | 2.02 (1.62–2.51) | 1.55 (1.18–2.02) |
| SO4 | 1.3 | 1.49 (1.30–1.71) | 1.54 (1.28–1.85) | 1.82 (1.33–2.50) | 1.61 (1.13–2.31) |
| NO3 | 3.6 | 1.40 (1.20–1.65) | 1.53 (1.24–1.88) | 1.86 (1.31–2.65) | 1.39 (0.90–2.13) |
| Fe | 0.06 | 1.23 (1.06–1.42) | 1.26 (1.04–1.52) | 1.61 (1.17–2.20) | 1.02 (0.68–1.53) |
| K | 0.05 | 1.90 (1.63–2.21) | 1.72 (1.40–2.11) | 2.59 (1.79–3.73) | 1.22 (0.82–1.82) |
| Si | 0.05 | 1.36 (1.25–1.49) | 1.44 (1.28–1.62) | 1.57 (1.27–1.94) | 1.43 (1.14–1.81) |
| Zn | 0.01 | 1.16 (1.06–1.27) | 1.18 (1.05–1.33) | 1.29 (1.06–1.56) | 1.09 (0.84–1.41) |
All models are adjusted for smoking status, total pack-years, BMI, marital status, alcohol consumption, second-hand smoke exposure at home, dietary fat, dietary fiber, dietary calories, physical activity, menopausal status, hormone replacement therapy use, family history of myocardial infarction or stroke, blood pressure medication and aspirin use, and contextual variables (income, income inequality, education, population size, racial composition, unemployment).
Association between mortality outcomes and PM2.5 and its constituents using 30-km buffer [HRs (95% CIs) for the IQR of each pollutant].
| Pollutant | IQR (μg/m3) | All cause ( | Cardiopulmonary ( | IHD ( | Pulmonary ( |
|---|---|---|---|---|---|
| PM2.5 | 6.1 | 1.45 (1.36–1.55) | 1.55 (1.43–1.69) | 1.91 (1.65–2.21) | 1.43 (1.21–1.69) |
| EC | 0.65 | 1.04 (0.95–1.14) | 1.07 (0.95–1.21) | 1.41 (1.14–1.74) | 0.91 (0.71–1.17) |
| OC | 0.83 | 1.73 (1.64–1.82) | 1.80 (1.68–1.93) | 2.03 (1.79–2.29) | 1.73 (1.51–1.97) |
| SO4 | 2.2 | 1.67 (1.52–1.83) | 1.79 (1.58–2.03) | 2.39 (1.93–2.97) | 1.59 (1.24–2.03) |
| NO3 | 3.2 | 1.32 (1.24–1.39) | 1.40 (1.29–1.51) | 1.66 (1.46–1.90) | 1.31 (1.13–1.52) |
| Fe | 0.13 | 1.22 (1.12–1.34) | 1.25 (1.10–1.42) | 1.66 (1.34–2.05) | 1.05 (0.82–1.35) |
| K | 0.07 | 1.43 (1.31–1.55) | 1.50 (1.34–1.68) | 2.06 (1.70–2.49) | 1.24 (0.99–1.55) |
| Si | 0.03 | 1.36 (1.32–1.40) | 1.39 (1.33–1.45) | 1.47 (1.37–1.59) | 1.35 (1.23–1.47) |
| Zn | 0.01 | 1.15 (1.07–1.25) | 1.21 (1.09–1.35) | 1.52 (1.27–1.82) | 1.06 (0.86–1.31) |
All models are adjusted for smoking status, total pack-years, BMI, marital status, alcohol consumption, second-hand smoke exposure at home, dietary fat, dietary fiber, dietary calories, physical activity, menopausal status, hormone replacement therapy use, family history of myocardial infarction or stroke, blood pressure medication and aspirin use, and contextual variables (income, income inequality, education, population size, racial composition, unemployment).
Associations with cardiopulmonary mortality using two-pollutant models and the 8-km buffer.
| Model | HR (95% CI) |
|---|---|
| OC | 1.64 (1.44–1.87) |
| OC | 1.67 (1.45–1.92) |
| EC | 0.97 (0.87–1.08) |
| OC | 1.81 (1.59–2.06) |
| SO4 | 1.90 (1.57–2.29) |
| OC | 1.59 (1.38–1.84) |
| NO3 | 1.13 (0.88–1.44) |
| OC | 1.63 (1.43–1.86) |
| Fe | 1.19 (0.98–1.44) |
| OC | 1.69 (1.37–2.08) |
| K | 0.94 (0.67–1.31) |
| OC | 1.55 (1.34–1.78) |
| Si | 1.29 (1.14–1.46) |
| OC | 1.62 (1.41–1.86) |
| Zn | 1.04 (0.91–1.19) |
| SO4 | 1.54 (1.28–1.85) |
| SO4 | 1.61 (1.29–2.00) |
| EC | 0.96 (0.85–1.08) |
| SO4 | 1.90 (1.57–2.29) |
| OC | 1.81 (1.59–2.06) |
| SO4 | 1.39 (1.13–1.72) |
| NO3 | 1.27 (1.00–1.61) |
| SO4 | 1.45 (1.14–1.83) |
| Fe | 0.90 (0.70–1.15) |
| SO4 | 1.53 (1.27–1.84) |
| K | 1.68 (1.37–2.04) |
| SO4 | 1.48 (1.22–1.79) |
| Si | 1.41 (1.26–1.59) |
| SO4 | 1.51 (1.21–1.87) |
| Zn | 1.02 (0.89–1.18) |
Figure 1Association of cardiopulmonary mortality with PM2.5 and its constituents using alternative exposure metrics: HR and 95% CI for 8-km buffer and cohort follow-up from June 2003 through July 2007.